Camena Bioscience

Camena Bioscience is a synthetic biology company founded in 2016, specializing in advanced enzymatic DNA synthesis technology through its proprietary gSynth® platform. This platform enables the high-throughput production of synthetic genes of any sequence, length, or complexity with superior accuracy compared to traditional methods. The company is headquartered in Chesterford Research Park, Essex, UK, and has operations in Cambridge and California. Camena's gSynth® platform utilizes a unique enzyme mix and the Cimban™ design algorithm to produce kilobases of DNA daily. This technology supports applications in vaccine development, cell and gene therapies, and multi-site editing. The company offers custom synthetic gene production and focuses on rapid, scalable DNA synthesis to meet the needs of the pharmaceutical and biotechnology sectors. Camena is committed to sustainable practices, aligning with the Science Based Targets Initiative to reduce environmental impact.